FDA Clears Test to Detect Bloodstream Infection Bacteria

The agency will allow marketing of the first nucleic acid test that can identify 12 different bacterial types known to cause bloodstream infections. FDA said the test produces results in a few hours after the first sign of bacterial growth.

The U.S. Food and Drug Administration announced it will allow the marketing of the first nucleic acid test that can identify 12 different bacterial types known to cause bloodstream infections. The test can simultaneously identify the bacteria and three associated resistance genes in a few hours after the first sign of bacterial growth, while traditional methods may require 2-4 days, according to the agency.

The Verigene GP Blood Culture Nucleic Acid Test manufactured by Nanosphere Inc. of Northbrook, Ill., can identify different types of Staphylococcus, (including methicillin-resistant Staphylococcus aureus or MRSA), Streptococcus, Enterococcus (including vancomycin-resistant Enterococci or VRE), and Listeria.

"Bloodstream infections are always treated with antimicrobial drugs, and it is essential to identify which antimicrobial drug is appropriate for a specific patient as quickly as possible," said Alberto Gutierrez, director of the Office of In Vitro Diagnostic Device Evaluation and Safety at FDA's Center for Devices and Radiological Health. "This new test is an important tool that will help physicians treat patients quickly with the correct antibiotics."

Bloodstream infections are a major issue for U.S. hospitals and a prime focus of their patient safety programs. FDA said its approval is based on a study of 1,642 patient blood samples obtained from incubated blood culture bottles that contained gram positive bacteria. When the test was compared with traditional blood culture lab methods, its results were consistent with traditional blood culture methods in 93 percent to 100 percent of the comparisons, according to the agency."

Download Center

HTML - No Current Item Deck
  • COVID-19 Return to Work Kit

    Streamline your return to work program and ensure your employees can get back safely with these resources created by certified occupational health, safety, and infectious disease experts.

  • 9 Common Questions About Behavior-Based Safety

    Renowned workplace safety expert Dr. Andrew Sharman answers 9 of the most pressing questions EHS professionals have about behavior-based safety programs.

  • COVID-19 Employee Health Screening Toolkit

    Powerful health assessment tools designed to help occupational health practitioners, employee health departments, and health and safety professionals conduct rapid workforce health screening to reduce the risk of infection and ensure business continuity.

  • RSIGuard Home Ergonomics Software

    Ensure you and your employees can work safely from home with a 6 month free trial of the RSIGuard desktop ergonomics software.

  • 5 Reasons You Should Embrace the Cloud for EHSQ Software

    EHSQ managers can realize reduced costs, increased productivity and enhanced software reliability when using SaaS.

  • Industry Safe

OH&S Digital Edition

  • OHS Magazine Digital Edition - June 2020

    June 2020

    Featuring:

    • FIRE SAFETY
      Recognizing and Mitigating Static Electricity Hazards
    • OIL & GAS
      New Gas Detection Technology
    • HEAT STRESS
      Stop Sweating Heat Stress
    • ELECTRICAL SAFETY
      Electricity is Everywhere
    View This Issue